Volker Schirrmacher

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Dendritic Cells

Endoplasmic Reticulum

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Volker Schirrmacher, Stefaan W van Gool, Wilfried Stuecker
Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution. Biomedicines 12 (4) (2024)
Volker Schirrmacher, Stefaan W van Gool, Wilfried Stuecker
Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution. Biomedicines 12 (4) (2024)
Peter Van De Vliet, Tobias Sprenger, Linde F C Kampers, Jennifer Makalowski, Volker Schirrmacher, Wilfried Stücker, Stefaan W van Gool
The Application of Evidence-Based Medicine in Individualized Medicine. Biomedicines 11 (7) (2023)
Stefaan W van Gool, Jennifer Makalowski, Peter Van de Vliet, Stefanie Van Gool, Tobias Sprenger, Volker Schirrmacher, Wilfried Stuecker
Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience. Cancers 15 (4) (2023)
Stefaan W van Gool, Jennifer Makalowski, Peter Van de Vliet, Stefanie Van Gool, Tobias Sprenger, Volker Schirrmacher, Wilfried Stuecker
Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience. Cancers 15 (4) (2023)
Stefaan W van Gool, Jennifer Makalowski, Peter Van de Vliet, Stefanie Van Gool, Tobias Sprenger, Volker Schirrmacher, Wilfried Stuecker
Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience. Cancers 15 (4) (2023)
Volker Schirrmacher
Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus. Biomedicines 10 (3) (2022)
Volker Schirrmacher, Stefaan van Gool, Wilfried Stuecker
Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy. International journal of molecular sciences 23 (21) (2022)
Volker Schirrmacher
Less Can Be More: The Hormesis Theory of Stress Adaptation in the Global Biosphere and Its Implications. Biomedicines 9 (3) (2021)
Volker Schirrmacher, Tobias Sprenger, Wilfried Stuecker, Stefaan W van Gool
Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit. Biomedicines 8 (8) (2020)
Stefaan W van Gool, Jennifer Makalowski, Simon Fiore, Tobias Sprenger, Lothar Prix, Volker Schirrmacher, Wilfried Stuecker
Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged. Cancers 13 (1) (2020)
Volker Schirrmacher
New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection. Biomedicines 8 (3) (2020)
Volker Schirrmacher
Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism. Biomedicines 8 (11) (2020)